Nanobiotix S.A. Cash Flows From Used In Financing Activities
Nanobiotix S.A. (NBTX) reported Cash Flows From Used In Financing Activities of EUR 37.42 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2026-03-31
| Period end | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|
| 2025-12-31 | 37.42M EUR 20-F · filed 2026-03-31 | |
| 2025-06-30 | -2.83M EUR 6-K · filed 2025-09-30 | |
| 2024-12-31 | -5.13M EUR 20-F · filed 2026-03-31 | |
| 2024-06-30 | -2.65M EUR 6-K · filed 2025-09-30 | |
| 2023-12-31 | 46.77M EUR 20-F · filed 2026-03-31 | |
| 2023-06-30 | -2.14M EUR 6-K · filed 2024-09-18 | |
| 2022-12-31 | -5.65M EUR 20-F · filed 2025-04-02 | |
| 2022-06-30 | -3.51M EUR 6-K · filed 2023-09-26 | |
| 2021-12-31 | -5.18M EUR 20-F · filed 2024-04-24 | |
| 2021-06-30 | -1.70M EUR 6-K · filed 2022-09-28 | |
| 2020-12-31 | 111.77M EUR 20-F · filed 2023-04-24 | |
| 2020-06-30 | 4.40M EUR 6-K · filed 2021-09-08 | |
| 2019-12-31 | 41.49M EUR 20-F · filed 2022-04-08 | |
| 2018-12-31 | 14.85M EUR 20-F/A · filed 2021-04-08 |